Posted Mar. 27, 2014 at 8:20 a.m.

Premium Lock BioDelivery Sciences picks Quintiles to help launch proposed drug

Published: 2014-03-27 08:20:31
Updated: 2014-03-27 08:20:31

How BDSI technology works How BDSI technology works

Raleigh-based BioDelivery Sciences recently raised $60 million to help commercialize its proposed chronic pain reliever drug and hopes to win FDA approval for it in June. On Thursday, BDSI said it had chosen Durham-based Quintiles, the world's largest life science services firm, to help take the drug to market. The deal includes formation of a sales force....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders